Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2Other 1

Conditions

Pain, Postoperative 3Head and Neck Neoplasms 2Trigger Finger Disorder 1Stomatitis 1Skin Neoplasms 1Rectal Neoplasms 1Pain 1Multiple Myeloma 1Mucositis 1Median Neuropathy 1Lymphoma 1Ileus 1Ganglion Cysts 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1De Quervain Disease 1Constipation 1Colonic Neoplasms 1Breast Neoplasms 1Agnosia 1Abnormalities, Radiation-Induced 1

Interventions

Cisplatin 257Radiotherapy 193Cetuximab 150pembrolizumab 123Docetaxel 96Fluorouracil 92Carboplatin 80Paclitaxel 78Radiotherapy, Intensity-Modulated 72Surveys and Questionnaires 46Nivolumab 42Drug Therapy 34Radiation 33Blood Specimen Collection 27Erlotinib Hydrochloride 26Gemcitabine 25Immunohistochemistry 22Gefitinib 22Surgical Procedures, Operative 21Cyclophosphamide 21durvalumab 19Standard of Care 19Pemetrexed 19Magnetic Resonance Spectroscopy 19Radiosurgery 17Capecitabine 17Chemotherapy, Adjuvant 16Celecoxib 16Biopsy 16atezolizumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × oxycodone-acetaminophen × Clear all
NCT01668849 2022-08-09

Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer

University of Louisville

Phase 1 Completed
60 enrolled
Head & Neck

Head and Neck Neoplasms, Stomatitis

NCT02480114 2021-02-18

Gabapentin Compared to Standard of Care in Preventing Mucositis in Patients With Stage III-IV Head and Neck Cancer Undergoing Primary or Adjuvant Chemoradiation Therapy

Vanderbilt-Ingram Cancer Center

Phase 3 Completed
79 enrolled 8 charts
Head & NeckOther

Abnormalities, Radiation-Induced, Head and Neck Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡